Business Wire February 19, 2020
Industry leaders, patient advocates, researchers unite to maximize the incredible potential of transformative gene therapies
WASHINGTON–The Institute for Gene Therapies (IGT) launched today with a focus on advocating for a modernized U.S. regulatory and reimbursement framework so that gene therapies can deliver their significant potential to patients. IGT will educate stakeholders across the healthcare community about the transformational nature of gene therapies and advocate for policies that help ensure patients who need them can benefit from them.
“Like so many diseases, CMT currently has no cure. I am proud to stand with other leading patient advocates, members of the research community and companies that are developing gene therapies to help ensure patients can...
Today's Sponsors
Today's Sponsor